Compare KeyCorp (KEY) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance

KeyCorpTrade

State Street SPDR S&P Biotech ETFTrade

Price performance (Past 24H)

Key statistics

KeyCorp vs State Street SPDR S&P Biotech ETF — how do they compare? KeyCorp trades at $23.55 (market cap $25.17B), while State Street SPDR S&P Biotech ETF trades at $154.43. The key difference: KeyCorp pays a 3.52% dividend while State Street SPDR S&P Biotech ETF pays none. Which is the better fit depends on your goals.

	KEY	XBI
Market Cap	$25.17B	—
Sector	Financials	Broad Market / Factor
52-Week High	$23.99	$164.28
52-Week Low	$16.78	$85.16
Dividend Yield	3.52%	—

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

KeyCorp

KeyCorp (KEY) trades at $22.95, down 2.55% today, but maintains strong fundamentals with a P/E of 14.31 and consistent earnings beats. The company reported Q2 2026 EPS of $0.44, beating estimates by 6.4%, driven by 7% revenue growth and expanding net interest margins. Technical indicators show a bullish moving average signal while oscillators remain neutral, with support at $23 and resistance at $24.

Outlook remains positive with analyst consensus price target of $31.06 (35% upside) and 61% buy ratings. Key risks include interest rate sensitivity and competitive banking pressures, but strong capital position and strategic acquisitions support growth trajectory through 2027.

State Street SPDR S&P Biotech ETF

No Aura AI signal available yet.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

KEY

KeyCorp grows US middle market and targets European M&A with UK advisory firm acquisitionPYMNTS · 8 hours agoBullish KeyCorp shows strong Q2, expands margins, and targets 7-8% stock gain with $25 price target.Seeking Alpha · 14 hours agoBullish KeyCorp Q2 2026 net income rises 22% YoY to $472M, driven by loan growth and strong fee income.PRNewsWire · 17 hours agoBullish View details →

XBI

Healthcare ETFs lead State Street's top 5 performers with pharma fund gaining 11.7% in the past monthETF Trends · 4 days agoBullish View details →

About KeyCorp

With assets of over $170 billion, Ohio-based KeyCorp's bank footprint spans 16 states, but it is predominantly concentrated in its two largest markets: Ohio and New York. KeyCorp is primarily focused on serving middle-market commercial clients through a hybrid community/corporate bank model.

About State Street SPDR S&P Biotech ETF

XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.